WHO suspends testing of hydroxycloroquine to treat COVID-19 patients

A recent study found a higher risk of death in critically ill coronavirus patients treated with the drug.
0:17 | 05/26/20

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for WHO suspends testing of hydroxycloroquine to treat COVID-19 patients
To the index the WHO suspended testing of high drug sykora Quinn to treat cold mid nineteen patients. A recent study found a higher risk of death and critically ill cope in nineteen patients treated with the anti malaria drug. President trump has repeatedly touted a drug even saying he took it. As a preventative measure.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"0:17","description":"A recent study found a higher risk of death in critically ill coronavirus patients treated with the drug. ","mediaType":"default","section":"ABCNews/WNT","id":"70874618","title":"WHO suspends testing of hydroxycloroquine to treat COVID-19 patients ","url":"/WNT/video/suspends-testing-hydroxycloroquine-treat-covid-19-patients-70874618"}